Biotech Tweets of the Week (October 19-23, 2015), featuring:
- It's not Always Blue Skies When N=1 $BLUE
- Biogen Beats Earnings but Outlook is Hazy $BIIB
- A New Bullseye on Valeant's Back $VRX
- "Approval is the new CRL" $RLYP $MACK
- Liver Safety Scare Rattles the HCV Market $ABBV $ENTA $ESRX $GILD
- And "Seen on the stream" recapping everything else new and noteworthy!